systemic lupus erythematosus

Showing 5 posts of 5 posts found.


UCB and Biogen’s lupus drug falls short at Phase 2b

October 24, 2018
Research and Development Biogen, Lupus, UCB, dapirolizumab pegol, pharma, systemic lupus erythematosus, trial falure

The partnership of UCB and Biogen announced disappointing news, confirming that its experimental therapy dapirolizumab pegol (DZP) failed to meet …


Ablynx’s vobarilizumab trial fails and sees two patient deaths in systemic lupus erythematosus

March 26, 2018
Research and Development, Sales and Marketing AbbVie, Ablynx, Sanofi, Vobarilizumab, pharma, systemic lupus erythematosus

Ablynx has revealed that its interleukin 6 pathway via its IL-6 receptor (IL-6R) vobarilizumab failed to meet its primary endpoint …


GSK ready for lupus drug push

November 12, 2015
Manufacturing and Production, Research and Development, Sales and Marketing Benlysta, GSK, Lupus, SLE, belimumab, systemic lupus erythematosus

Having presented positive late-stage results for a new formulation of its inflammatory drug Benlysta, GSK says it will file supplementary …

systemic lupus erythematosus (SLE)

US approval for GSK’s lupus treatment Benlysta

March 10, 2011
Sales and Marketing Benlysta, GSK, GlaxoSmithKline, Human Genome Sciences, Lupus, belimumab, systemic lupus erythematosus

GlaxoSmithKline’s lupus treatment Benylsta has won an historic approval in the US, but will have to prove its safety record …

systemic lupus erythematosus

UCB lupus candidate shows disease benefits

November 11, 2010
Benlysta, Lupus, UCB, epratuzumab, monoclonal antibody, systemic lupus erythematosus

A new monoclonal antibody targeting the autoimmune disease lupus is continuing to show a positive effect on sufferers, its manufacturer …

Latest content